Accuracy, safety, efficiency and speed are essential for successful clinical trials. Since the studies are mainly carried out internationally, the investigational medicinal products must be reliably labeled and have all the important information in several languages. Sanofi needed a multi-page label for this, on which the product information is available in many different languages. In addition, it should adhere firmly to the plastic needle protection system and should not affect the functionality of the system. The booklet label developed by Schreiner MediPharm is wrapped closely around the needle protection system. The compact booklet comprises 32 pages with medication information in 22 languages. It adheres reliably to the plastic base of the needle protection system and can be easily wrapped around the square device thanks to the flexible material construction made of thin booklet paper plus layers of film. A grip tab allows the label to be opened and closed comfortably. The booklet label is partially attached to the device so that the pre-filled syringe and its contents are clearly visible after it has been opened. In order to be able to remove the booklet before the injection, it is equipped with a perforation - only a small part of the label, which can contain variable data, for example, remains on the device afterwards. The Schreiner MediPharm Clinical Trial Supplies (CTS) team is a competence and service partner for clinical studies. It has extensive expertise in the field of clinical trial supplies and advises all customers individually and flexibly according to their needs. A specialized process center for booklet labels creates reliable solutions that are optimally adapted to the respective packaging of the investigational medicinal products. About Sanofi Sanofi is a global healthcare company headquartered in Paris with more than 100,000 employees. The group is represented in over 100 countries, with global sales of around 34.5 billion euros in 2018. More than 15,000 Sanofi employees on three continents research and develop new medicines and vaccines.
